Corrigendum to “Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation” [J. Pharm. Anal. 13 (2023) 11–23]AuthorsGaofu LiNingning Wang (ORCID: https://orcid.org/0009-0002-4299-9732)Baokun HeYuwei GaoHuifang DengChengcai LaiLei ZhouEntao LiLanxin YueRina SuYue GaoWei ZhouInstitutionsTianjin University of Traditional Chinese Medicine (CN)Shanghai Jiao Tong University (CN)Shanghai First People's Hospital (CN)Chinese Academy of Agricultural Sciences (CN)Jilin Agricultural University (CN)Publication DetailsJournalJournal of Pharmaceutical AnalysisPublished2025-12-22DOIhttps://doi.org/10.1016/j.jpha.2025.101517Primary Topicinterferon and immune responsesTypearticleField-Weighted Citation Impact0.00Explore the Global Research Space Interactive Map